[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Gefitinib.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Gefitinib.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Gefitinib.]
[G03BA03, testosterone, Gefitinib may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Gefitinib.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Tetracaine.]
[A04AD10, dronabinol, The metabolism of Gefitinib can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Gefitinib.]
[L04AX02, thalidomide, The metabolism of Gefitinib can be increased when combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Gefitinib.]
[N05AC02, thioridazine, The metabolism of Gefitinib can be decreased when combined with Thioridazine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Gefitinib.]
[V04CJ01, thyrotropin, The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Gefitinib.]
[V04CJ02, thyrotropin-releasing hormone, The therapeutic efficacy of Protirelin can be decreased when used in combination with Gefitinib.]
[B01AC05, ticlopidine, The metabolism of Gefitinib can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Gefitinib.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Gefitinib.]
[N06AF04, tranylcypromine, The metabolism of Gefitinib can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Gefitinib.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Gefitinib.]
[S01BA05, triamcinolone, The metabolism of Gefitinib can be increased when combined with Triamcinolone.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Gefitinib.]
[R03BA07, mometasone, The metabolism of Gefitinib can be increased when combined with Mometasone.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Gefitinib.]
[R06AC04, tripelennamine, The metabolism of Gefitinib can be decreased when combined with Tripelennamine.]
[J01FA08, troleandomycin, The metabolism of Gefitinib can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Gefitinib can be decreased when combined with Vilazodone.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Gefitinib can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Gefitinib can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Gefitinib can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Gefitinib can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[B01AF01, rivaroxaban, Gefitinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Gefitinib.]
[C08DA01, verapamil, The metabolism of Gefitinib can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Gefitinib can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Gefitinib can be decreased when combined with Vinblastine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Gefitinib.]
[B01AA03, warfarin, Gefitinib may increase the anticoagulant activities of Warfarin.]
[J05AF01, zidovudine, Gefitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Gefitinib.]
[J05AE02, indinavir, The metabolism of Gefitinib can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, Gefitinib may decrease the excretion rate of Vemurafenib which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Gefitinib.]
[A02BC04, rabeprazole, Rabeprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE04, ziprasidone, The metabolism of Gefitinib can be decreased when combined with Ziprasidone.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Gefitinib.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Gefitinib.]
[J02AC03, voriconazole, The serum concentration of Gefitinib can be increased when it is combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Gefitinib.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Gefitinib.]
[H02AB11, prednylidene, The metabolism of Gefitinib can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Gefitinib.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Gefitinib.]
[A08AA11, lorcaserin, The metabolism of Gefitinib can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Gefitinib can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Gefitinib can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Gefitinib can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The metabolism of Gefitinib can be increased when combined with Enzalutamide.]
[L04AA31, teriflunomide, Gefitinib may decrease the excretion rate of Teriflunomide which could result in a higher serum level.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AC02, calcium silicate, Calcium silicate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Gefitinib can be decreased when combined with Nelfinavir.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Gefitinib.]
[N06DA02, donepezil, Gefitinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Gefitinib.]
[G04BD10, darifenacin, The metabolism of Gefitinib can be decreased when combined with Darifenacin.]
[G04BE03, sildenafil, The metabolism of Gefitinib can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Gefitinib.]
[B01AF02, apixaban, Gefitinib may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Gefitinib.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Gefitinib can be decreased when combined with Glycerol phenylbutyrate.]
[G03XC05, ospemifene, The metabolism of Gefitinib can be decreased when combined with Ospemifene.]
[A06AX06, tegaserod, The metabolism of Gefitinib can be decreased when combined with Tegaserod.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Gefitinib.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Gefitinib can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Gefitinib can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Gefitinib.]
[L01EC02, dabrafenib, The serum concentration of Gefitinib can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Benzyl alcohol.]
[H05AA03, parathyroid hormone, The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Gefitinib.]
[L01EB03, afatinib, Gefitinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Gefitinib.]
[J05AJ03, dolutegravir, Gefitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C08EA02, bepridil, The metabolism of Gefitinib can be decreased when combined with Bepridil.]
[C02KX05, riociguat, Gefitinib may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Gefitinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Gefitinib.]
[J05AP05, simeprevir, The metabolism of Gefitinib can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Gefitinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Gefitinib.]
[C07AB04, acebutolol, The metabolism of Gefitinib can be decreased when combined with Acebutolol.]
[A16AA07, metreleptin, The metabolism of Gefitinib can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Gefitinib can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Gefitinib can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Gefitinib.]
[L04AC11, siltuximab, The metabolism of Gefitinib can be increased when combined with Siltuximab.]
[B01AA07, acenocoumarol, Gefitinib may increase the anticoagulant activities of Acenocoumarol.]
[L01EM01, idelalisib, Gefitinib may decrease the excretion rate of Idelalisib which could result in a higher serum level.]
[N07XX08, tafamidis, The serum concentration of Gefitinib can be increased when it is combined with Tafamidis.]
[A16AX10, eliglustat, The metabolism of Gefitinib can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Gefitinib can be decreased when combined with Oritavancin.]
[N04AA02, biperiden, The metabolism of Gefitinib can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Gefitinib.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Gefitinib.]
[B01AA01, dicumarol, Gefitinib may increase the anticoagulant activities of Dicoumarol.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Gefitinib.]
[L04AC10, secukinumab, The metabolism of Gefitinib can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, Gefitinib may decrease the excretion rate of Palbociclib which could result in a higher serum level.]
[L01EX08, lenvatinib, Gefitinib may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Gefitinib can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N02BE01, acetaminophen, The serum concentration of Acetaminophen can be increased when it is combined with Gefitinib.]
[B01AA11, tioclomarol, Gefitinib may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Gefitinib can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Gefitinib.]
[A04AD14, rolapitant, The metabolism of Gefitinib can be decreased when combined with Rolapitant.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02BC03, lansoprazole, Lansoprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Gefitinib.]
[J02AC05, isavuconazole, The metabolism of Gefitinib can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Gefitinib may decrease the excretion rate of Osimertinib which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Gefitinib.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01XX52, venetoclax, The metabolism of Gefitinib can be decreased when combined with Venetoclax.]
[A02AD05, aluminum magnesium silicate, Almasilate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Bupivacaine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Gefitinib.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Gefitinib.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Gefitinib.]
[M02AA03, clofezone, Rabeprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX07, azelastine, The metabolism of Gefitinib can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Gefitinib can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Gefitinib can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Gefitinib.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Oxybuprocaine.]
[A12AA04, calcium carbonate, Calcium carbonate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AE09, tipranavir, The metabolism of Gefitinib can be decreased when combined with Tipranavir.]
[H03BA03, benzylthiouracil, The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Gefitinib.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Gefitinib.]
[L04AB02, infliximab, The metabolism of Gefitinib can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Gefitinib can be increased when combined with Midostaurin.]
[H05AA04, abaloparatide, The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Gefitinib.]
[L01ED04, brigatinib, Gefitinib may decrease the excretion rate of Brigatinib which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[J01MA23, delafloxacin, Gefitinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Gefitinib.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Gefitinib.]
[L01EF03, abemaciclib, Gefitinib may decrease the excretion rate of Abemaciclib which could result in a higher serum level.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AG03, efavirenz, The metabolism of Gefitinib can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Gefitinib.]
[R03BA02, budesonide, The metabolism of Gefitinib can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Gefitinib can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Capsaicin.]
[A10BK04, ertugliflozin, Gefitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[L02BB05, apalutamide, The metabolism of Gefitinib can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Gefitinib can be increased when combined with Carbamazepine.]
[H03BB01, carbimazole, The therapeutic efficacy of Carbimazole can be decreased when used in combination with Gefitinib.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Gefitinib.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[V03AE10, sodium zirconium cyclosilicate, Sodium zirconium cyclosilicate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Gefitinib.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Gefitinib.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Gefitinib.]
[L01XX62, ivosidenib, The metabolism of Gefitinib can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Gefitinib.]
[N03AX17, stiripentol, The metabolism of Gefitinib can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Gefitinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Gefitinib.]
[L01EM04, duvelisib, Gefitinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Gefitinib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Chloroprocaine.]
[L01XK04, talazoparib, Gefitinib may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[R03BB08, revefenacin, Gefitinib may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Gefitinib.]
[L04AA39, emapalumab, The metabolism of Gefitinib can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L01XJ03, glasdegib, Gefitinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Gefitinib.]
[P02BX04, triclabendazole, The metabolism of Gefitinib can be decreased when combined with Triclabendazole.]
[J01FA09, clarithromycin, The metabolism of Gefitinib can be decreased when combined with Clarithromycin.]
[N05BA09, clobazam, The metabolism of Gefitinib can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Gefitinib can be increased when combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Gefitinib can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Gefitinib can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Gefitinib.]
[L02BB06, darolutamide, The serum concentration of Gefitinib can be increased when it is combined with Darolutamide.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N07XX11, pitolisant, The serum concentration of Gefitinib can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Gefitinib.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Gefitinib.]
[N02CC08, lasmiditan, The serum concentration of Gefitinib can be increased when it is combined with Lasmiditan.]
[N03AX25, cenobamate, The serum concentration of Gefitinib can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Gefitinib can be increased when it is combined with Givosiran.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Gefitinib.]
[R06AB02, dexchlorpheniramine, The metabolism of Gefitinib can be decreased when combined with Dexchlorpheniramine.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Gefitinib.]
[L01XX72, tazemetostat, Gefitinib may decrease the excretion rate of Tazemetostat which could result in a higher serum level.]
[M01AX21, diacetylrhein, The metabolism of Gefitinib can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Gefitinib.]
[H02CA02, osilodrostat, The metabolism of Gefitinib can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Gefitinib can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Gefitinib.]
[L04AA38, ozanimod, Gefitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, Gefitinib may decrease the excretion rate of Selumetinib which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Gefitinib.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Gefitinib.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Gefitinib.]
[C01BD07, dronedarone, The metabolism of Gefitinib can be decreased when combined with Dronedarone.]
[S03AA08, chloramphenicol, The metabolism of Gefitinib can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Gefitinib.]
[L01EX17, capmatinib, The serum concentration of Gefitinib can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Gefitinib can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Gefitinib can be decreased when combined with Trospium.]
[L01EX19, ripretinib, Gefitinib may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Dyclonine.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Gefitinib.]
[J05AX29, fostemsavir, Gefitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Gefitinib can be decreased when combined with Proguanil.]
[L04AC19, satralizumab, The serum concentration of Gefitinib can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The metabolism of Oliceridine can be decreased when combined with Gefitinib.]
[P01BA01, chloroquine, The metabolism of Gefitinib can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, Gefitinib may decrease the excretion rate of Pralsetinib which could result in a higher serum level.]
[R06AB04, chlorpheniramine, The metabolism of Gefitinib can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Gefitinib can be decreased when combined with Chlorpromazine.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Gefitinib.]
[A11CC05, cholecalciferol, The metabolism of Gefitinib can be decreased when combined with Cholecalciferol.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Gefitinib.]
[A16AX20, lonafarnib, The metabolism of Gefitinib can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Gefitinib.]
[P03AX07, abametapir, The serum concentration of Gefitinib can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[V03AF12, trilaciclib, Gefitinib may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Gefitinib.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Gefitinib.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Gefitinib.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The metabolism of Gefitinib can be decreased when combined with Peginterferon alfa-2b.]
[G03GA06, follitropin beta, The therapeutic efficacy of Follitropin can be decreased when used in combination with Gefitinib.]
[A02BA01, cimetidine, Cimetidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Gefitinib.]
[L01XX73, sotorasib, The serum concentration of Gefitinib can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Gefitinib can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Gefitinib can be decreased when combined with Citalopram.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Gefitinib.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Gefitinib.]
[R06AA04, clemastine, The metabolism of Gefitinib can be decreased when combined with Clemastine.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Gefitinib.]
[N06AX25, St. John's wort extract, The metabolism of Gefitinib can be increased when combined with St. John's Wort.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Gefitinib can be decreased when combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Gefitinib can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Gefitinib.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Gefitinib.]
[C01EB24, mavacamten, The serum concentration of Gefitinib can be decreased when it is combined with Mavacamten.]
[J02AC06, oteseconazole, The serum concentration of Gefitinib can be increased when it is combined with Oteseconazole.]
[A02BC08, vonoprazan, Vonoprazan can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Gefitinib.]
[N05AH02, clozapine, The metabolism of Gefitinib can be decreased when combined with Clozapine.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Gefitinib can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Gefitinib can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Gefitinib.]
[L04AA13, leflunomide, Gefitinib may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Gefitinib.]
[J01FA15, telithromycin, The metabolism of Gefitinib can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Gefitinib.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Gefitinib.]
[J02AC02, itraconazole, The metabolism of Gefitinib can be decreased when combined with Itraconazole.]
[L01EA01, imatinib, The serum concentration of Gefitinib can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Gefitinib can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, Esomeprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gefitinib.]
[S01BA03, cortisone, The metabolism of Gefitinib can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Gefitinib.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA11, manidipine, The metabolism of Gefitinib can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Gefitinib.]
[H02AB15, meprednisone, The metabolism of Gefitinib can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Gefitinib.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Gefitinib.]
[N05AD03, metylperon, The metabolism of Gefitinib can be decreased when combined with Melperone.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Gefitinib.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Gefitinib.]
[S01XA18, cyclosporine, The metabolism of Gefitinib can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Gefitinib can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Gefitinib can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, Gefitinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Gefitinib can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Gefitinib.]
[M01AH05, etoricoxib, The metabolism of Gefitinib can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, Gefitinib may decrease the excretion rate of Dactinomycin which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Gefitinib can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Gefitinib can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, Gefitinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Gefitinib.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Gefitinib.]
[N06AX06, nefazodone, The metabolism of Gefitinib can be decreased when combined with Nefazodone.]
[N06AB10, escitalopram, The serum concentration of Gefitinib can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Gefitinib.]
[N06AA01, desipramine, The metabolism of Gefitinib can be decreased when combined with Desipramine.]
[L01XA03, oxaliplatin, Gefitinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Gefitinib can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Gefitinib can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Gefitinib can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Gefitinib.]
[L04AB04, adalimumab, The metabolism of Gefitinib can be increased when combined with Adalimumab.]
[S01AA13, fusidic acid, The metabolism of Gefitinib can be decreased when combined with Fusidic acid.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Gefitinib.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Gefitinib.]
[H05AA02, teriparatide, The therapeutic efficacy of Teriparatide can be decreased when used in combination with Gefitinib.]
[N06AB05, paroxetine, The metabolism of Gefitinib can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Gefitinib.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Gefitinib.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Cinchocaine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Gefitinib.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Gefitinib can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Gefitinib can be increased when combined with Difluocortolone.]
[C10AX09, ezetimibe, Gefitinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Gefitinib can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Gefitinib.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Gefitinib can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Gefitinib can be decreased when combined with Dimethyl sulfoxide.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Diphenhydramine.]
[A03FA02, cisapride, The metabolism of Gefitinib can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Gefitinib.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Gefitinib.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Gefitinib.]
[S02AA12, rifamycin SV, The metabolism of Gefitinib can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Gefitinib can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Gefitinib may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Gefitinib.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Gefitinib.]
[A04AD12, aprepitant, The metabolism of Gefitinib can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Gefitinib.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Gefitinib.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Gefitinib.]
[C01EB18, ranolazine, The serum concentration of Gefitinib can be increased when it is combined with Ranolazine.]
[R03AC12, salmeterol, The metabolism of Salmeterol can be decreased when combined with Gefitinib.]
[H05BA01, salmon calcitonin, The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gefitinib.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Gefitinib.]
[N06AA16, dothiepin, The metabolism of Gefitinib can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, Doxepin can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01DB01, doxorubicin, Gefitinib may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Gefitinib.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Gefitinib.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CC01, sumatriptan, Gefitinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Gefitinib.]
[D01BA02, terbinafine, The metabolism of Gefitinib can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Gefitinib.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Gefitinib.]
[G03GA05, follitropin alfa, The therapeutic efficacy of Follitropin can be decreased when used in combination with Gefitinib.]
[L01CA04, vinorelbine, Gefitinib may increase the neutropenic activities of Vinorelbine.]
[S01GX10, epinastine, Epinastine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AX16, venlafaxine, The metabolism of Gefitinib can be decreased when combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Gefitinib can be decreased when combined with Barnidipine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Gefitinib.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Gefitinib.]
[N02CA02, ergotamine, The metabolism of Gefitinib can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Gefitinib can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, Pantoprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H05BX01, cinacalcet, The metabolism of Gefitinib can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Gefitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[J04AK02, ethambutol, The metabolism of Gefitinib can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Gefitinib can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Gefitinib can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Gefitinib.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Gefitinib.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Gefitinib.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Gefitinib.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Gefitinib.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Gefitinib.]
[A02BA04, nizatidine, Nizatidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Gefitinib.]
[R06AX12, terfenadine, The metabolism of Gefitinib can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Gefitinib can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Gefitinib can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Gefitinib.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[A02BA03, famotidine, Famotidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA02, felodipine, The metabolism of Gefitinib can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The metabolism of Gefitinib can be decreased when combined with Fenfluramine.]
[L01BB06, clofarabine, Gefitinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Gefitinib may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Gefitinib.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Gefitinib.]
[J02AC01, fluconazole, The metabolism of Gefitinib can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Gefitinib.]
[D07AC08, fluocinonide, The metabolism of Gefitinib can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Gefitinib can be increased when combined with Fluocortolone.]
[L01BC02, fluorouracil, Gefitinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N06AB03, fluoxetine, The serum concentration of Gefitinib can be increased when it is combined with Fluoxetine.]
[N05AB02, fluphenazine, The metabolism of Gefitinib can be decreased when combined with Fluphenazine.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Gefitinib.]
[V04CX02, folic acid, Gefitinib may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Gefitinib.]
[J05AE10, darunavir, The metabolism of Gefitinib can be decreased when combined with Darunavir.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Gefitinib.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Gefitinib.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Gefitinib.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Gefitinib.]
[A10BB01, glyburide, Gefitinib may decrease the excretion rate of Glyburide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The metabolism of Gefitinib can be decreased when combined with Dexmedetomidine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Gefitinib.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gefitinib.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Gefitinib.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Gefitinib.]
[B01AA12, fluindione, Gefitinib may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Gefitinib can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Gefitinib.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Gefitinib.]
[L01CE02, irinotecan, Gefitinib may decrease the excretion rate of Irinotecan which could result in a higher serum level.]
[M04AA01, allopurinol, Gefitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AG01, nevirapine, The metabolism of Gefitinib can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Gefitinib can be decreased when combined with Nilvadipine.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Gefitinib.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Gefitinib.]
[P01BA02, hydroxychloroquine, The metabolism of Gefitinib can be decreased when combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The metabolism of Gefitinib can be decreased when combined with Hydroxyzine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Gefitinib.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Gefitinib.]
[N06AA02, imipramine, The metabolism of Gefitinib can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Gefitinib.]
[L01CE01, topotecan, Gefitinib may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Gefitinib can be decreased when combined with Milnacipran.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Articaine.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Gefitinib.]
[C10AA06, cerivastatin, Gefitinib may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[C07AA01, alprenolol, The metabolism of Alprenolol can be decreased when combined with Gefitinib.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Gefitinib.]
[N06AF05, iproniazid, The metabolism of Gefitinib can be decreased when combined with Iproniazid.]
[N04BX02, entacapone, The metabolism of Gefitinib can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Gefitinib can be decreased when combined with Isoniazid.]
[P02CF01, ivermectin, Gefitinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N06AX18, reboxetine, The metabolism of Gefitinib can be decreased when combined with Reboxetine.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Gefitinib can be increased when combined with Tocilizumab.]
[J02AB02, ketoconazole, The metabolism of Gefitinib can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, Olanzapine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA24, abatacept, The metabolism of Gefitinib can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Gefitinib can be decreased when combined with Rotigotine.]
[C07AG01, labetalol, The metabolism of Gefitinib can be decreased when combined with Labetalol.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Gefitinib.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Gefitinib can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Gefitinib.]
[C10AA02, lovastatin, The metabolism of Gefitinib can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Gefitinib.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01BA05, pralatrexate, Gefitinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Gefitinib can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Gefitinib.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Gefitinib.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Gefitinib.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Mepivacaine.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Gefitinib.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Gefitinib.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Gefitinib.]
[N07BC02, methadone, The metabolism of Gefitinib can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Gefitinib.]
[A03AB07, methantheline, Methantheline can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AF05, lamivudine, Gefitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, The metabolism of Gefitinib can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, Gefitinib may decrease the excretion rate of Methotrexate which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The metabolism of Gefitinib can be decreased when combined with Methotrimeprazine.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Gefitinib.]
[V04CG05, methylene blue, The metabolism of Gefitinib can be decreased when combined with Methylene blue.]
[A03FA01, metoclopramide, The metabolism of Gefitinib can be decreased when combined with Metoclopramide.]
[C07AB02, metoprolol, The metabolism of Gefitinib can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Gefitinib.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Gefitinib.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Gefitinib.]
[S02AA13, miconazole, The metabolism of Gefitinib can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Gefitinib.]
[N05CD08, midazolam, The metabolism of Midazolam can be decreased when combined with Gefitinib.]
[G03XB01, mifepristone, The metabolism of Gefitinib can be decreased when combined with Mifepristone.]
[L01XX23, mitotane, The metabolism of Gefitinib can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, Gefitinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Gefitinib.]
[C01BD01, amiodarone, The metabolism of Gefitinib can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Gefitinib.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Gefitinib.]
[L04AB05, certolizumab pegol, The metabolism of Gefitinib can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[L01EX03, pazopanib, Gefitinib may decrease the excretion rate of Pazopanib which could result in a higher serum level.]
[G03XC01, raloxifene, Gefitinib may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Gefitinib.]
[N03AB05, fosphenytoin, The metabolism of Gefitinib can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Gefitinib.]
[V03AB15, naloxone, The metabolism of Gefitinib can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Gefitinib can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Gefitinib.]
[A10BG01, troglitazone, The metabolism of Gefitinib can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Gefitinib can be decreased when combined with Duloxetine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gefitinib.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Gefitinib.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Gefitinib.]
[N06AX23, desvenlafaxine, The metabolism of Gefitinib can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Gefitinib can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The metabolism of Gefitinib can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Gefitinib can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Gefitinib.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Gefitinib.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Gefitinib.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Gefitinib.]
[J01XE01, nitrofurantoin, Gefitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Gefitinib.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Gefitinib.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Gefitinib.]
[L04AC04, rilonacept, The metabolism of Gefitinib can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Gefitinib.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Gefitinib.]
[P02BA02, oxamniquine, The metabolism of Gefitinib can be decreased when combined with Oxamniquine.]
[C07AA02, oxprenolol, The metabolism of Gefitinib can be decreased when combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Gefitinib.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Gefitinib.]
[N05AH05, asenapine, Asenapine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AB05, paramethasone, The metabolism of Gefitinib can be increased when combined with Paramethasone.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Gefitinib.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Gefitinib.]
[N05CA01, pentobarbital, The metabolism of Gefitinib can be increased when combined with Pentobarbital.]
[C08EX02, perhexiline, The metabolism of Gefitinib can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Gefitinib can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Gefitinib.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Gefitinib.]
[B01AA02, phenindione, Gefitinib may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Gefitinib can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Gefitinib may increase the anticoagulant activities of Phenprocoumon.]
[A02BC06, dexlansoprazole, Dexlansoprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AB02, phenytoin, The metabolism of Gefitinib can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Gefitinib can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Gefitinib can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Gefitinib.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Gefitinib.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Gefitinib.]
[J05AE01, saquinavir, The metabolism of Gefitinib can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Gefitinib.]
[N05AC04, pipothiazine, The metabolism of Gefitinib can be decreased when combined with Pipotiazine.]
[J05AG02, delavirdine, The metabolism of Gefitinib can be decreased when combined with Delavirdine.]
[L04AC08, canakinumab, The metabolism of Gefitinib can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Gefitinib can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Gefitinib.]
[V03AB21, potassium iodide, The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Gefitinib.]
[C10AA08, pitavastatin, Gefitinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Gefitinib.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Gefitinib.]
[C02CA01, prazosin, Gefitinib may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Gefitinib can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Gefitinib can be increased when combined with Primidone.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Gefitinib.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Procaine.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Gefitinib.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Gefitinib.]
[R06AD02, promethazine, Promethazine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C01BC03, propafenone, The metabolism of Gefitinib can be decreased when combined with Propafenone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Gefitinib.]
[N02AC04, propoxyphene, The metabolism of Gefitinib can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Gefitinib.]
[H03BA02, propylthiouracil, The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Gefitinib.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Gefitinib.]
[R06AC01, pyrilamine, The metabolism of Gefitinib can be decreased when combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Gefitinib.]
[C01BA01, quinidine, The metabolism of Gefitinib can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Gefitinib can be decreased when combined with Quinine.]
[A02BA02, ranitidine, Ranitidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C02AA02, reserpine, The metabolism of Gefitinib can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Gefitinib can be increased when combined with Rifampicin.]
[A07EC01, sulfasalazine, Gefitinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Gefitinib.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Gefitinib.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Gefitinib.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Gefitinib.]
[H02CA04, levoketoconazole, The metabolism of Gefitinib can be decreased when combined with Levoketoconazole.]
